GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.

Also called NCT07166133

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07166133
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07166133. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03-02 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Condition
Aortic Arch Dissection
Condition
Aortic Arch Aneurysm
Intervention (Device)
GORE® TAG® Thoracic Branch Endoprosthesis
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct07166133
Content hash
e4117892e79bca479e4e56ba8c7387c17b5a9a6604f74a51b17efabdf997d229